Financials
Financial year 2025
ISA PHARMA from Orp-Jauche, company number BE0835600362, closed financial year 2025 with a result of € 34,498 after tax. For that financial year ISA PHARMA recorded a gross margin of € 209,801 and equity of € 181,475. Compared with financial year 2024, the result moved from € 24,829 to € 34,498. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.
€ 181,475
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 34,498
▲ 39% vs 2024
Profit after tax over the fiscal year.
€ 146,413
▲ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 21,067 paid out
61 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 146,138
▼ 1% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 987
▼ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 72,416
▼ 12% vs 2024
€ 12,966 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 38,373
▲ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 31,459
▲ 36% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 186,861 | € 181,387 | € 197,473 | € 209,801 | ▲ 6% |
| Profit after taxes | € 52,502 | € 30,151 | € 24,829 | € 34,498 | ▲ 39% |
| Equity | € 123,036 | € 152,354 | € 168,044 | € 181,475 | ▲ 8% |
| Total debts | € 185,128 | € 175,250 | € 143,074 | € 164,778 | ▲ 15% |
| Cash | € 121,692 | € 84,520 | € 121,011 | € 146,413 | ▲ 21% |
| Land & buildings | € 84,038 | € 74,715 | € 76,771 | € 67,373 | ▼ 12% |
| Retained profit | € 110,636 | € 138,094 | € 153,784 | € 167,215 | ▲ 9% |
| Dividend | € 21,200 | € 833 | € 9,139 | € 21,067 | ▲ 131% |
| Bank debt | € 99,011 | € 90,181 | € 81,988 | € 72,416 | ▼ 12% |
| Balance sheet total | € 308,163 | € 327,604 | € 311,118 | € 346,253 | ▲ 11% |
Key figures of ISA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ISA PHARMA?
What happened at ISA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 34,498 (▲ 39% vs 2024). filed late Source: NBB ↗
- ISABELLE STRAET became a director. NBB
- New establishment in Orp-Jauche. KBO
- Start of the company according to the CBE. KBO
In short
From € 52,502 profit in 2022 to € 34,498 profit in 2025.
Paid € 55,267 in corporate taxes since 2022.
Best year ever: 2022, with € 52,502 profit.
Paid out € 52,239 in dividends to the owners in total.
Management
Behind ISA PHARMA is ISABELLE STRAET.
Directors
According to the 2025 annual accounts
ISABELLE STRAET
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Avenue Albert Drossart(J) 23
1350 Orp-Jauche
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0835.600.362
- VAT number
- BE 0835.600.362
- Registered office
- Avenue Albert Drossart(J) 23, 1350 Orp-Jauche
- Names & denominations
- ISA PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 April 2011
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten